Pediatric Oncology Series Editors: Gregory H. Reaman · Franklin O. Smith Thomas E. Merchant Rolf-Dieter Kortmann Editors Pediatric Radiation Oncology Pediatric Oncology Series Editors: Gregory H. Reaman Silver Spring, MD, USA Franklin O. Smith Cincinnati, OH, USA More information about this series at http://www.springer.com/series/5421 Thomas E. Merchant Rolf-Dieter Kortmann Editors Pediatric Radiation Oncology Editors Thomas E. Merchant Rolf-Dieter Kortmann Department of Radiation Oncology Department of Radiation Oncology St Jude Children’s Research Hospital University of Leipzig Memphis, TN Leipzig, Germany USA ISSN 1613-5318 ISSN 2191-0812 (electronic) Pediatric Oncology ISBN 978-3-319-43544-2 ISBN 978-3-319-43545-9 (eBook) https://doi.org/10.1007/978-3-319-43545-9 Library of Congress Control Number: 2017960210 © Springer International Publishing Switzerland 2018 This work is subject to copyright. All rights are reserved by the Publisher, whether the whole or part of the material is concerned, specifically the rights of translation, reprinting, reuse of illustrations, recitation, broadcasting, reproduction on microfilms or in any other physical way, and transmission or information storage and retrieval, electronic adaptation, computer software, or by similar or dissimilar methodology now known or hereafter developed. The use of general descriptive names, registered names, trademarks, service marks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant protective laws and regulations and therefore free for general use. The publisher, the authors and the editors are safe to assume that the advice and information in this book are believed to be true and accurate at the date of publication. Neither the publisher nor the authors or the editors give a warranty, express or implied, with respect to the material contained herein or for any errors or omissions that may have been made. The publisher remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Printed on acid-free paper This Springer imprint is published by Springer Nature The registered company is Springer International Publishing AG The registered company address is: Gewerbestrasse 11, 6330 Cham, Switzerland Preface Cancer is the leading cause of death by disease past infancy among children in the Western world. In the United States in 2014, it is estimated that 15,780 children and adolescents from birth to the age of 19 years will be diagnosed with cancer and 1960 will die of the disease (Ward et al. 2014). In 1975, only barely above 50% of children diagnosed with cancer before age 20 years sur- vived more than 5 years (Ries et al. 1999). Since then results have greatly improved such that in 2004–2010 more than 80% of children diagnosed with cancer before age 20 years survived at least 5 years (Howlader et al. 2014, National Cancer Institute, http://www.cancer.gov). Childhood malignancies include a great variety of different tumor types for most of which multidisci- plinary management with a combination of local and systemic treatments is required for optimal outcomes; for many patients, radiation therapy as local treatment is an integral component of the therapeutic strategy. Pediatric malignancies are a challenge for the radiation oncologist due to their rarity, the great variability of histological subtypes, and the complexity of treatment concepts that undergo constant modification. Radiation therapy technologies also undergo a continuous process of optimization and modern technologies (e.g., intensity-modulated radiotherapy, proton therapy, inclu- sion of modern imaging in treatment planning, and use of imaging to pre- cisely guide treatment delivery) are rapidly becoming essential in the management of children and teenagers with malignancies. This book addresses the most recent developments in radiation therapy with respect to the different types of childhood malignancies and the use of modern treat- ment technologies. The chapters also address specific issues in the field of anesthesia, palliative radiation therapy, and quality of life. The book is therefore designed to provide a comprehensive overview of current and future treatment concepts with emphasis on radiation therapy. Special attention is paid to experiences on past and present trials worldwide With the increase of the childhood population in low and middle income countries, specific demands will be put on the management of childhood can- cer in an environment with limited access to modern technologies. This book therefore also addresses aspects for low and middle income countries. v vi Preface Ries LAG, Smith MA, Gurney JG, et al (eds) (1999) Cancer Incidence and survival among children and adolescents: United States SEER Program 1975–1995. National Cancer Institute, SEER Program. NIH Pub. No. 99-4649. Bethesda, MD Howlader N, Noone AM, Krapcho M, et al (eds) (2014) SEER cancer statis- tics review, 1975–2011, National Cancer Institute. Bethesda, MD, http:// seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site Memphis, TN, USA Thomas E. Merchant, D.O., Ph.D. Leipzig, Germany Rolf-Dieter Kortmann, M.D. Contents 1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 Thomas E. Merchant and Rolf-Dieter Kortmann 2 Ewing Sarcoma and Desmoplastic Small Round Cell Tumor . . . 3 Safia K. Ahmed, Siddhartha Laskar, and Nadia N. Laack 3 Pediatric Rhabdomyosarcoma . . . . . . . . . . . . . . . . . . . . . . . . . . . . 21 Stephanie Terezakis and Matthew Ladra 4 The Non-rhabdomyosarcoma Soft Tissue Sarcomas, Desmoid Tumor and Osteosarcoma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 45 Christopher L. Tinkle and John T. Lucas Jr. 5 Neuroblastoma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 87 Joseph Panoff, John Lucas, Luke Pater, and Shefali Gajjar 6 Wilms Tumor . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 111 John A. Kalapurakal 7 Rare Tumors in Pediatric Oncology . . . . . . . . . . . . . . . . . . . . . . . 131 Jeffrey C. Buchsbaum, Jeannette Parkes, and Thanushree Naidoo 8 Pediatric Glioma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 171 Erin Murphy, Matthew Poppe, and Rakesh Jalali 9 Medulloblastoma/Non-Medulloblastoma Embryonal Tumors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 203 Stephanie M. Perkins, Efrat Landau, and Christine Hill-Kayser 10 Atypical Teratoid/Rhabdoid Tumor (AT/RT) . . . . . . . . . . . . . . . . 221 Eman Al Duhaiby, Christopher Tinkle, and Paul Aridgides 11 CNS Germ Cell Tumors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 243 Erin Murphy, Shannon MacDonald, and Frank Saran 12 Childhood Ependymoma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 257 Rosangela Correa Villar and Thomas E. Merchant 13 Childhood Craniopharyngioma . . . . . . . . . . . . . . . . . . . . . . . . . . . 277 Thomas E. Merchant vii viii Contents 14 Hematopoietic Stem Cell Transplantation . . . . . . . . . . . . . . . . . . 301 Natia Esiashvili and Michael A. Pulsipher 15 Utilization of Radiation for Pediatric Hodgkin Lymphoma . . . . 313 Bradford S. Hoppe, Ronica H. Nanda, and Anne-Marie Charpentier 16 Basic Principles and Advances in Technology Used for Pediatric Radiotherapy. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 343 Arthur J. Olch and Chia-Ho Hua 17 Proton Therapy for Pediatric Malignancies . . . . . . . . . . . . . . . . . 363 Matthew D. Hall, Daniel J. Indelicato, Ronny Rotondo, and Julie A. Bradley 18 Helical TomoTherapy in Pediatric-Adolescent Patients . . . . . . . 381 Maurizio Mascarin and Elisa Coassin 19 Localization, Verification, and Anesthesia . . . . . . . . . . . . . . . . . . 407 Ralph Ermoian, Michael Rossi, Chris Beltran, and Sally Rampersad 20 Palliative Radiotherapy and Management of the Pediatric Oncology Patient . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 419 Tamara Vern-Gross and Karen Marcus 21 Pediatric Radiotherapy in Low and Middle Income Countries . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 451 Natia Esiashvili, Verity Ahern, Jeannette Parkes, Hester Burger, Yavuz Anacak, and Siddhartha Laskar 22 Future Directions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 461 Thomas E. Merchant and Rolf-Dieter Kortmann 1 Introduction Thomas E. Merchant and Rolf-Dieter Kortmann Cancer is the leading cause of death by disease Pediatric malignancies are a challenge for the past infancy among children in the Western world. radiation oncologist due to their rarity, the great In the United States in 2014, it is estimated that variability of histological subtypes, and the com- 15,780 children and adolescents from birth to the plexity of treatment concepts that continue to age of 19 years will be diagnosed with cancer and evolve. Radiation treatment methods, both tech- 1960 will die of the disease (Ward et al. 2014). In nology and process, undergo a continuous pro- 1975, fewer than 50% of children diagnosed with cess of optimization. Poignant example include cancer before the age of 20 years survived more intensity modulated radiotherapy, proton therapy, than 5 years (Ries et al. 1999). Since then results inclusion of modern imaging for treatment plan- have greatly improved. In 2004–2010 more than ning, localization, and verification. All methods 80% of children diagnosed with cancer before age and modalities associated with contemporary 20 years survived at least 5 years (Howlader et al. adult treatment are essential to the management 2013, National Cancer Institute, http://www.can- of children and young adults with cancer and cer.gov). Childhood malignancies include a vari- allied diseases. This work addresses the most ety of different tumour types. Most require recent developments in radiation therapy with multidisciplinary management with a combina- respect to the different types of childhood can- tion of local and systemic treatments to achieve cers and conditions that require irradiation. Each optimal outcomes; for many patients, radiation chapter addresses specific issues in the field of therapy as local treatment is an integral compo- pediatric radiation oncology by disease, disci- nent of the therapeutic strategy. pline, and topic relevant to the treatment of chil- dren and young adults. This work is designed to provide a comprehensive overview of current and future concepts with emphasis on radiation ther- apy. Experience based on past and present trials are given priority. T.E. Merchant, D.O., Ph.D. (*) With the increase of the childhood population Department Radiation Oncology, St. Jude Children’s in low and medium income countries specific Research Hospital, 262 Danny Thomas Place, MS 210, Memphis, TN 38105-3678, USA demands will be put on the management of child- e-mail: [email protected] hood cancer in an environment with limited R.-D. Kortmann, M.D. access to modern technologies. This work Department of Radiation Therapy, University of addresses certain challenges associated with low Leipzig, Stephanstr. 9a, 04103 Leipzig, Germany and medium income countries. e-mail: [email protected] © Springer International Publishing Switzerland 2018 1 T.E. Merchant, R.-D. Kortmann (eds.), Pediatric Radiation Oncology, Pediatric Oncology, https://doi.org/10.1007/978-3-319-43545-9_1 2 T.E. Merchant and R.-D. Kortmann References NIH Pub. No. 99–4649, National Cancer Institute, SEER Program, Bethesda, MD Howlader N, Noone AM, Krapcho M, et al (eds) (2013) Ward E, DeSantis C, Robbins A et al (2014) Childhood SEER cancer statistics review, 1975–2011. National and adolescent cancer statistics, 2014. CA Cancer J Cancer Institute. Bethesda, MD, http://seer.cancer. Clin 64(2):83–103. doi:10.3322/caac.21219 gov/csr/1975_2011/, based on November 2013 SEER Ries LAG, Smith MA, Gurney JG, et al (eds) (1999) data submission, posted to the SEER web site, April Cancer incidence and survival among children and 2014 adolescents: United States SEER program 1975–1995.
Description: